ZA846209B - Method for labeling phagocytic cells - Google Patents

Method for labeling phagocytic cells

Info

Publication number
ZA846209B
ZA846209B ZA846209A ZA846209A ZA846209B ZA 846209 B ZA846209 B ZA 846209B ZA 846209 A ZA846209 A ZA 846209A ZA 846209 A ZA846209 A ZA 846209A ZA 846209 B ZA846209 B ZA 846209B
Authority
ZA
South Africa
Prior art keywords
labeling
phagocytic cells
phagocytic
cells
labeling phagocytic
Prior art date
Application number
ZA846209A
Other languages
English (en)
Original Assignee
Vestar Research Inc
Hope Nat Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US06/465,502 priority Critical patent/US4497791A/en
Priority to AU24417/84A priority patent/AU574346B2/en
Priority to JP59022707A priority patent/JPS59193360A/ja
Priority to DE8484300854T priority patent/DE3485400D1/de
Priority to CA000447188A priority patent/CA1248474A/fr
Priority to EP84300854A priority patent/EP0127925B1/fr
Application filed by Vestar Research Inc, Hope Nat Medical Center filed Critical Vestar Research Inc
Priority to ZA846209A priority patent/ZA846209B/xx
Priority to ZA863345A priority patent/ZA863345B/xx
Publication of ZA846209B publication Critical patent/ZA846209B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1227—Micelles, e.g. phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA846209A 1983-02-10 1984-08-10 Method for labeling phagocytic cells ZA846209B (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US06/465,502 US4497791A (en) 1983-02-10 1983-02-10 Method for labeling phagocytic cells
AU24417/84A AU574346B2 (en) 1983-02-10 1984-02-09 Micellular particle labelled leukocytes and phagocytic cells
JP59022707A JPS59193360A (ja) 1983-02-10 1984-02-09 食細胞の標識方法
DE8484300854T DE3485400D1 (de) 1983-02-10 1984-02-10 Verfahren zur markierung von phagozytischen zellen.
CA000447188A CA1248474A (fr) 1983-02-10 1984-02-10 Methode de marquage des cellules phagocytaires
EP84300854A EP0127925B1 (fr) 1983-02-10 1984-02-10 Méthode de marquage de cellules phagocytaires
ZA846209A ZA846209B (en) 1983-02-10 1984-08-10 Method for labeling phagocytic cells
ZA863345A ZA863345B (en) 1984-08-10 1986-02-10 Labelled phagocytic cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/465,502 US4497791A (en) 1983-02-10 1983-02-10 Method for labeling phagocytic cells
ZA846209A ZA846209B (en) 1983-02-10 1984-08-10 Method for labeling phagocytic cells

Publications (1)

Publication Number Publication Date
ZA846209B true ZA846209B (en) 1986-12-30

Family

ID=27041325

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA846209A ZA846209B (en) 1983-02-10 1984-08-10 Method for labeling phagocytic cells

Country Status (7)

Country Link
US (1) US4497791A (fr)
EP (1) EP0127925B1 (fr)
JP (1) JPS59193360A (fr)
AU (1) AU574346B2 (fr)
CA (1) CA1248474A (fr)
DE (1) DE3485400D1 (fr)
ZA (1) ZA846209B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441745A (en) * 1982-03-30 1995-08-15 Vestar, Inc. Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US5435989A (en) 1982-03-30 1995-07-25 Vestar, Inc. Method of targeting a specific location in a body
US5387410A (en) * 1983-03-18 1995-02-07 Mallinckrodt, Inc. Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution
US4636380A (en) * 1984-04-23 1987-01-13 Wong Dennis W Novel physiologic chemical method of labeling protein substances with the radionuclides of indium
US4634586A (en) * 1984-05-21 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Reagent and method for radioimaging leukocytes
US5019369A (en) * 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US4935223A (en) * 1988-08-04 1990-06-19 Board Of Regents, The University Of Texas System Labeled cells for use in imaging
US5145661A (en) * 1988-08-31 1992-09-08 Wayne State University Method and contrast agent for use in magnetic resonance imaging of abscess
US5045304A (en) * 1988-08-31 1991-09-03 Wayne State University Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess and a method of preparing and using same
US5078986A (en) * 1989-02-15 1992-01-07 Mallinckrodt Medical, Inc. Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
FR2660864A1 (fr) * 1990-04-13 1991-10-18 Guerbet Sa Composition de contraste, procede de preparation de cette composition et application a l'imagerie.
US5158760A (en) * 1990-05-30 1992-10-27 Board Of Regents, The University Of Texas System 99m TC labeled liposomes
US5552155A (en) * 1992-12-04 1996-09-03 The Liposome Company, Inc. Fusogenic lipsomes and methods for making and using same
DE19500665A1 (de) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel
US5601997A (en) 1995-02-03 1997-02-11 Tchao; Ruy Chemotaxis assay procedure
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
CN115901582A (zh) * 2022-12-06 2023-04-04 中国辐射防护研究院 一种α粒子照射人肝细胞后细胞周期的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375459A (en) * 1980-06-20 1983-03-01 The Regents Of The University Of California Cytoreceptor assay
JPS5719664A (en) * 1980-07-10 1982-02-01 Sogo Seibutsu Igaku Kenkyusho:Kk Measuring method for human helper t cell function

Also Published As

Publication number Publication date
EP0127925A2 (fr) 1984-12-12
AU2441784A (en) 1984-08-16
CA1248474A (fr) 1989-01-10
EP0127925A3 (en) 1986-04-16
US4497791A (en) 1985-02-05
AU574346B2 (en) 1988-07-07
JPH0354307B2 (fr) 1991-08-19
DE3485400D1 (de) 1992-02-13
EP0127925B1 (fr) 1992-01-02
JPS59193360A (ja) 1984-11-01

Similar Documents

Publication Publication Date Title
ZA846209B (en) Method for labeling phagocytic cells
GB2159990B (en) Method for securely communicating
ZA857297B (en) Apparatus for making photovoltaic modules
DE3479285D1 (en) Method for peel development
DE3476056D1 (en) Apparatus for producing labels
IL75093A (en) Method for encapsulating articles
AU568835B2 (en) Generator for radionuclide
GB2132935B (en) Method for manufacturing containers
GB8304311D0 (en) Labelling station
GB2144118B (en) Method for preparing 4-methylionone
IL72792A0 (en) Process for labeling phagocytic cells
JPS57163631A (en) Labelling method
BG49226A1 (en) Method for preparing carnitindehydrogenase
BG39329A1 (en) Method for chromogastroscopy
ZA838719B (en) Method for isolating cells
IE842102L (en) Labelling phagocytic cells
BG36111A1 (en) Method for preparing 1- chlorcarbonyl- 2- oxo- imidazolidine
BG35374A1 (en) Method for preparing yttrium- aluminium granate
BG35827A1 (en) Method for preparing polynitrourethanes
BG35961A1 (en) Method for preparing polycyclosiloxanes
BG36110A1 (en) Method for preparing 5- nitro- 7- chlor- 8- hydroquinoline
BG36109A1 (en) Method for preparing 5- chlor- 7- iodo- 8- hydroxyquinoline
BG35984A1 (en) Method for preparing silicobarium
BG36846A1 (en) Method for preparing 1- benzhydryl- 4- cynamylpiperazine
BG36712A1 (en) Method for preparing beta- glucosidase